Clinical Trial Results with Novel Agents and Regimens for the Treatment of Newly Diagnosed or Relapsed/Refractory AML/MDS, Including in the Elderly


Clinical Trial Results with Novel Agents and Regimens for the Treatment of Newly Diagnosed or Relapsed/Refractory AML/MDS, Including in the Elderly
Slides from presentations at ASCO 2011 and comments from Susan M O’Brien, MD

Pollyea DA et al. Sequential azacitidine and lenalidomide in elderly acute myeloid leukemia: Completed results of the phase I study. Proc ASCO 2011;Abstract 6505.

Dr O'Brien is Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.